ভাঙ্গন এবং হাড় টিস্যু resorption যে ফাংশন ঘরের

osteoclast's Usage Examples:

An osteoclast (from Ancient Greek ὀστέον (osteon) 'bone', and κλαστός (clastos) 'broken') is a type of bone cell that breaks down bone tissue.

activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is a protein that in humans is encoded by.

by the action of osteoclasts.

This is a normal physiological process in the exfoliation of the primary dentition, caused by osteoclast differentiation.

Under normal circumstances, TRAP is highly expressed by osteoclasts, activated macrophages, neurons, and by the porcine endometrium during.

resorption is resorption of bone tissue, that is, the process by which osteoclasts break down the tissue in bones and release the minerals, resulting in.

(RANKL) and part of the RANK/RANKL/OPG signaling pathway that regulates osteoclast differentiation and activation.

NF-κB ligand (RANKL)–induced osteoclast differentiation.

Pepstatin A suppresses the formation of multinuclear osteoclasts dose-dependently.

It is characterized by the presence of multinucleated giant cells (osteoclast-like cells).

during the differentiation of osteoclast precursor cells into mature osteoclasts, known as osteoclastogenesis.

Mature osteoclasts then bind to bone through.

during osteoclast differentiation.

More specifically, miR-223 expression suppresses the differentiation of osteoclast precursors into osteoclast thus making.

suggests that kahweol may have beneficial effects on bone by inhibiting osteoclast differentiation.

New bone is deposited by osteoblast cells and resorbed or destroyed by osteoclast cells.

It is also known as LRF10 (leukemia/lymphoma-related factor), OCZF11 (osteoclast-derived zinc finger), and FBI1 (1-3) (fourteen-three-three beta interactant).

shown to stimulate osteoclast differentiation and function.

Studies have found that blockade of the A1 Receptor suppresses the osteoclast function, leading.

cells, although different functions have been described, for example an osteoclast maturation.

The brown tumor is a bone lesion that arises in settings of excess osteoclast activity, such as hyperparathyroidism.

AE2 is required for normal osteoclast function.

IL-32 can also support osteoclast differentiation but not osteoclast activation by regulating the MAPK/ERK pathway and the.

osteoclast's Meaning':

cell that functions in the breakdown and resorption of bone tissue